Philip Morris considers selling stake in pharmaceuticals unit to boost healthcare division

The company's wellness division has struggled, and Philip Morris has had talks with Deutsche Bank on a range of options.

from Health and Science https://ift.tt/loaq2kF
https://ift.tt/wBhnCiD
https://ift.tt/FgVHfbc